Literature DB >> 11352121

Cholestatic syndromes of infancy and childhood.

J A Bezerra1, W F Balistreri.   

Abstract

Cholestasis results from structural and functional impairment of the hepatobiliary system, which is often the target of several environmental factors and disease processes. This review focuses on the clinical consequences of this impairment. When evaluating an infant or child with cholestasis, a broad differential diagnosis must be considered; viral infections, metabolic disorders, and toxic insults may often lead to cholestasis. In the infant, cholestasis associated with severe hepatic synthetic dysfunction points to life-threatening metabolic disorders. In this setting, early diagnosis and prompt treatment offer the only chance for survival. Fortunately, cholestasis in infants presents more frequently with initially normal liver synthetic function. In those infants without evidence of infection, evaluation for patency of the extra-hepatic biliary system is a high priority. Biliary atresia comprises a significant portion of these patients and requires surgical intervention with portoenterostomy in an attempt to improve biliary flow. In a substantial group of infants and older children in whom the cause for cholestasis is not apparent, typical clinical and biochemical markers may allow the identification of specific genetic defects of syndromes that result from abnormal canalicular transporters.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352121

Source DB:  PubMed          Journal:  Semin Gastrointest Dis        ISSN: 1049-5118


  7 in total

Review 1.  Zebrafish models of human liver development and disease.

Authors:  Benjamin J Wilkins; Michael Pack
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

2.  Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis.

Authors:  Chee-Seng Lee; Akihiko Kimura; Jia-Feng Wu; Yen-Hsuan Ni; Hong-Yuan Hsu; Mei-Hwei Chang; Hiroshi Nittono; Huey-Ling Chen
Journal:  J Lipid Res       Date:  2017-01-10       Impact factor: 5.922

3.  Pathologic causes of liver disease in Sudanese children: Results of 450 liver needle biopsies at a single children hospital.

Authors:  Omayma M Sabir
Journal:  Sudan J Paediatr       Date:  2011

4.  Study of predictive value of pediatric risk of mortality (PRISM) score in children with end stage liver disease and fulminant hepatic failure.

Authors:  Hanaa M El-Karaksy; Mortada M El-Shabrawi; Nabil A Mohsen; Nehal M El-Koofy; Wafaa A El-Akel; Mona E Fahmy; Noha A Yassin
Journal:  Indian J Pediatr       Date:  2010-10-20       Impact factor: 1.967

5.  Biopsy-driven diagnosis in infants with cholestatic jaundice in Iran.

Authors:  Elham Talachian; Ali Bidari; Mitra Mehrazma; Nahid Nick-khah
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

6.  Evaluation of cholestasis in Iranian infants less than three months of age.

Authors:  Seyed Mohsen Dehghani; Neda Efazati; Iraj Shahramian; Mahmood Haghighat; Mohammad Hadi Imanieh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

7.  p53-mediated biliary defects caused by knockdown of cirh1a, the zebrafish homolog of the gene responsible for North American Indian Childhood Cirrhosis.

Authors:  Benjamin J Wilkins; Kristin Lorent; Randolph P Matthews; Michael Pack
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.